Skip to main content
February 22, 2021
MDMA-assisted psychotherapy for the treatment of alcohol use disorder was found to improve psychosocial functioning with no unexpected adverse events in a clinical trial conducted by London-based Awakn Life Sciences. Results of the study were published in the Journal of Psychopharmacology.
February 16, 2021
A low dose of naltrexone was found to be a promising alternative to opioids prescribed for patients with orofacial and chronic pain, according to a new study from the University of Michigan School of Dentistry. The study was published in the Journal of the American Dental Association.
February 01, 2021
With drug overdose deaths reaching historic levels during the COVID-19 pandemic, researchers from the Lerner Center for Public Health Promotion at Syracuse University noted how inconsistent prescribing of anti-anxiety medications has been a significant contributing factor and will continue to be…
October 05, 2020
The Indiana University School of Medicine has received a $12.3 million grant from the National Institute on Drug Abuse for a two-stage research project to study the use of tezampanel to treat opioid withdrawal syndrome, as well as other addictions and mental illnesses. Proniras Corp., a Seattle-…
August 31, 2020
Not-for-profit organization Mothers Against Prescription Drug Abuse, life sciences firm Emergent BioSolutions, and three Major League Baseball clubs are teaming up to raise awareness for overdose reversal medications among the general public.
August 24, 2020
While most Americans are now taking the threat of opioid addiction seriously, a new study shows fewer than 1 in 4 can accurately identify medications that contain opioids. In a survey of more than 1,000 U.S. adults conducted on behalf of DrFirst, a healthcare technology and consulting services…
August 18, 2020
In an effort to reduce the risk of death from opioid overdose, the FDA recently made a series of recommendations around naloxone for both healthcare professionals and patients.
May 18, 2020
Researchers from Beaumont Health System in Michigan are studying whether a medication used to treat opioid addiction can be used to help manage symptoms of individuals with a COVID-19 infection, according to a report from WDET-FM, Detroit’s NPR affiliate. Matthew Sims, MD, PhD, chief infectious…
April 28, 2020
A new study suggests buprenorphine may help treat cocaine addiction, however such treatment itself creates a potential for addiction and therefore is not approved by the FDA, according to a report published this week by Science Magazine. A recently studied analog for the medication, however, is…
April 21, 2020
Not only does Lisa McLaughlin see the now-waived requirement of an initial face-to-face patient visit for initiating buprenorphine as not medically necessary, she considers it damaging for some patients' prospects for getting into recovery.
Back to Top